AQR Capital Management
PFE icon

AQR Capital Management’s Pfizer PFE Stock Holding History

AQR Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$334M Buy
11,879,235
+2,059,402
+21% +$54.8M 0.15% 174
2025
Q4 		$245M Buy
9,819,833
+314,218
+3% +$7.92M 0.13% 201
2025
Q3 		$231M Buy
9,505,615
+5,202,884
+121% +$128M 0.15% 179
2025
Q2 		$104M Sell
4,302,731
-1,773,951
-29% -$41.4M 0.09% 326
2025
Q1 		$151M Sell
6,076,682
-622,115
-9% -$16.3M 0.16% 169
2024
Q4 		$178M Buy
6,698,797
+5,021,915
+299% +$136M 0.23% 85
2024
Q3 		$48.5M Buy
1,676,882
+1,064,453
+174% +$31.1M 0.07% 384
2024
Q2 		$17.1M Buy
612,429
+9,435
+2% +$260K 0.03% 624
2024
Q1 		$16.7M Sell
602,994
-1,136,826
-65% -$31.5M 0.03% 574
2023
Q4 		$50.1M Sell
1,739,820
-3,403,378
-66% -$103M 0.09% 263
2023
Q3 		$169M Sell
5,143,198
-262,490
-5% -$9.28M 0.35% 59
2023
Q2 		$196M Sell
5,405,688
-3,977,138
-42% -$155M 0.42% 43
2023
Q1 		$380M Sell
9,382,826
-456,997
-5% -$19.7M 0.83% 8
2022
Q4 		$503M Sell
9,839,823
-845,459
-8% -$40.5M 1.15% 4
2022
Q3 		$468M Buy
10,685,282
+120,527
+1% +$5.86M 1.14% 5
2022
Q2 		$554M Sell
10,564,755
-138,739
-1% -$7.07M 1.25% 5
2022
Q1 		$554M Buy
10,703,494
+3,857,765
+56% +$200M 1.05% 7
2021
Q4 		$404M Buy
6,845,729
+1,190,989
+21% +$59M 0.73% 17
2021
Q3 		$243M Buy
5,654,740
+252,045
+5% +$11.2M 0.45% 34
2021
Q2 		$210M Buy
5,402,695
+78,542
+1% +$3.05M 0.36% 53
2021
Q1 		$192M Buy
5,324,153
+1,030,309
+24% +$36.6M 0.31% 62
2020
Q4 		$156M Sell
4,293,844
-4,037,020
-48% -$148M 0.28% 83
2020
Q3 		$290M Sell
8,330,864
-2,150,201
-21% -$75.4M 0.49% 41
2020
Q2 		$325M Sell
10,481,065
-1,181,888
-10% -$40.2M 0.53% 30
2020
Q1 		$361M Sell
11,662,953
-2,343,291
-17% -$79.8M 0.61% 26
2019
Q4 		$517M Buy
14,006,244
+333,914
+2% +$11.9M 0.59% 24
2019
Q3 		$466M Sell
13,672,330
-6,669,689
-33% -$243M 0.55% 28
2019
Q2 		$836M Sell
20,342,019
-5,842,397
-22% -$232M 0.93% 12
2019
Q1 		$1.05B Sell
26,184,416
-2,530,775
-9% -$101M 1.11% 5
2018
Q4 		$1.19B Buy
28,715,191
+4,313,237
+18% +$179M 1.38% 3
2018
Q3 		$1.02B Buy
24,401,954
+9,171,171
+60% +$353M 0.98% 12
2018
Q2 		$526M Sell
15,230,783
-1,656,058
-10% -$56.6M 0.53% 36
2018
Q1 		$569M Sell
16,886,841
-3,233,983
-16% -$111M 0.61% 29
2017
Q4 		$691M Sell
20,120,824
-1,864,636
-8% -$63.6M 0.73% 19
2017
Q3 		$745M Buy
21,985,460
+6,563,146
+43% +$211M 0.89% 5
2017
Q2 		$491M Buy
15,422,314
+3,963,008
+35% +$125M 0.65% 19
2017
Q1 		$372M Buy
11,459,306
+589,490
+5% +$18.6M 0.49% 35
2016
Q4 		$335M Buy
10,869,816
+604,059
+6% +$18.4M 0.46% 39
2016
Q3 		$330M Buy
10,265,757
+1,932,577
+23% +$64.6M 0.51% 29
2016
Q2 		$278M Sell
8,333,180
-190,915
-2% -$6.09M 0.49% 25
2016
Q1 		$240M Sell
8,524,095
-9,866,333
-54% -$282M 0.43% 41
2015
Q4 		$563M Buy
18,390,428
+560,455
+3% +$17.6M 0.99% 3
2015
Q3 		$531M Buy
17,829,973
+2,798,475
+19% +$89.7M 1.06% 3
2015
Q2 		$478M Buy
15,031,498
+1,394,978
+10% +$45.5M 0.95% 7
2015
Q1 		$450M Sell
13,636,520
-1,049,324
-7% -$33.4M 1.03% 3
2014
Q4 		$434M Buy
14,685,844
+3,665,871
+33% +$105M 0.91% 5
2014
Q3 		$309M Buy
11,019,973
+63,330
+0.6% +$1.78M 0.85% 6
2014
Q2 		$309M Buy
10,956,643
+997,986
+10% +$28.4M 0.83% 4
2014
Q1 		$303M Buy
9,958,657
+1,761,023
+21% +$52.5M 0.92% 4
2013
Q4 		$238M Buy
8,197,634
+925,307
+13% +$26.9M 0.71% 10
2013
Q3 		$198M Sell
7,272,327
-4,113,582
-36% -$112M 0.7% 11
2013
Q2 		$303M Buy
+11,385,909
New +$315M 1.07% 2

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

AQR Capital Management's PFE Position: Q1 2026 in Review

AQR Capital Management increased its Pfizer (PFE) stake by 21% in Q1 2026, buying an estimated $54.8M and bringing the position to 11,879,235 shares worth $334M. The position accounts for 0.15% of the portfolio, ranked #174.

AQR Capital Management first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.19B in Q4 2018. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • AQR Capital Management held 11,879,235 shares of Pfizer worth $334M as of Q1 2026.
  • AQR Capital Management bought 2,059,402 Pfizer shares in Q1 2026, an estimated $54.8M.
  • Pfizer made up 0.15% of AQR Capital Management's portfolio in Q1 2026, its #174 holding.
  • AQR Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
  • AQR Capital Management's Pfizer position peaked at $1.19B in Q4 2018.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on AQR Capital Management's 13F filing for Q1 2026, filed 15 May 2026.